Modulating cell survival by modulating huntingtin function
CA 2376655 A1 · Owner: Hayden, Michael R. · Inventors: Hayden, Michael R.; Leavitt, Blair R.; Hackam, Abigail S.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a means of modulating cell survival by modulating wild-type huntingtin protein function by administration of wildtype huntingtin protein, biologically active fragments thereof and/or antagonists of wild-type huntingtin. Accordingly the present invention also , provides biologically active fragments of wild-type huntingtin antagonists of , wild-type huntingtin and nucleic acid sequences encoding the biologically active fragments and peptide antagonists and their use to modulate cell , survival. In particular the invention provides for means to activate or attenuate cell death within tissue, in order to facilitate the treatment of conditions where there is …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 12, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 12, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 12, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.